Jim Cramer's top 10 things to watch in the stock market Thursday
Walmart is selling off on disappointing earnings, and analysts are divided on Merck after its cancer vaccine breakthrough.
Walmart is selling off on disappointing earnings, and analysts are divided on Merck after its cancer vaccine breakthrough. This story matters for Finance & Markets readers tracking broker. Reported by cnbc.com. Read the full original at the source link below.
Originally reported by cnbc.com. BrokerNews curates and briefs the finance & markets stories that matter. Our editorial policy →